tiprankstipranks
AbbVie (GB:0QCV)
LSE:0QCV

AbbVie (0QCV) Stock Investors

3 Followers
Based on 722,977 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

1.5% of all portfolios hold GB:0QCV
On average, investors allocate 5.83% of their portfolios to GB:0QCV
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 722,977 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0QCV

0.2%
Last 7
Days
0.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0QCV, out of 722,977 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0QCV Investor Activity

No data currently available
Based on the activity of 13,599 investors who made their portfolios public
The table shows changes in 0QCV in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0QCV Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.04%
+0.19%
+0.58%
313.67B
Healthcare
Cisco Systems
4.56%
-0.41%
-0.58%
201.57B
Technology
Raytheon Technologies
4.10%
-0.30%
-0.77%
127.03B
Industrials
Micron
5.59%
+10.90%
+26.10%
122.04B
Technology
Caterpillar
4.64%
+0.32%
+2.12%
178.83B
Industrials
Home Depot
5.05%
-0.03%
+2.48%
386.77B
Consumer Cyclical
Citigroup
5.11%
-0.02%
+0.52%
116.25B
Financial
Target
4.45%
-0.57%
+3.02%
77.85B
Consumer Cyclical
Qualcomm
4.85%
-0.20%
+2.09%
189.83B
Technology
Johnson & Johnson
4.72%
+0.15%
-1.01%
373.91B
Healthcare
Based on the activity of 722,977 active portfolios
Open your Smart Portfolio

0QCV Investor Analysis

GB:0QCV investors under 35

Under 35

3.9%
Last 30 days
Holdings Change
12.8%
of GB:0QCV holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
GB:0QCV investors between 35–55

Between 35–55

0.9%
Last 30 days
Holdings Change
50.0%
of GB:0QCV holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
GB:0QCV investors over 55

Over 55

1.3%
Last 30 days
Holdings Change
37.1%
of GB:0QCV holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of GB:0QCV stock investors
See who invests in 0QCV according to age group and performance.

FAQ

How many retail Investors hold GB:0QCV?
1.5% of TipRanks' retail investors hold GB:0QCV in their portfolios.
    What is GB:0QCV Investor Sentiment?
    GB:0QCV’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of GB:0QCV in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of GB:0QCV in the last 7 days.
        What percentage of retail investors changed their holding of GB:0QCV in the last 30 days?
        ▲ 0.6% of TipRanks' retail investors changed their holding of GB:0QCV in the last 30 days.
          What is the average age of retail investors who hold GB:0QCV?
          The average age of GB:0QCV Holders is between 35–55.
            What other stocks have GB:0QCV investors also bought?
            GB:0QCV Investors also bought MRK, CSCO, RTX, MU, CAT, HD, C, TGT, QCOM, JNJ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              AZNAstraZeneca
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis